Joshua Rottner

Partner
Full contact info

I enjoy helping entrepreneurs turn their ideas into a business, and then advising the business as it matures from a startup all the way to a liquidity event such as an M&A sale or IPO.

Passions

Skiing

Travelling

Spending time with my wife and three children

Experience

IN8bio – $40 Million IPO

August 4, 2021

Cooley advised IN8Bio on its $40 million initial public offering of 4,000,000 shares of common stock. IN8Bio, whose securities now trade on the Nasdaq Global Market under the symbol INAB, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell therapies. Partners Josh Kaufman, Jaime Chase and Josh Rottner led the Cooley team.

Related contacts

Josh Kaufman
Partner, New York
Jaime L. Chase
Partner, Washington DC
Joshua Rottner
Partner, Boston

Related Practices & Industries

Jive Communications Sells to LogMeIn for $342 Million

February 8, 2018

Cooley advised Jive Communications, a leading provider of cloud-based phone systems and unified communications services, on its agreement to sell to LogMeIn. Partners Miguel Vega and Joshua Rottner led the team advising Jive on the transaction.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Joshua Rottner
Partner, Boston
J.G. Harrington
Special Counsel, Washington DC
Sarah O'Gorman
Associate, Boston

Related Practices & Industries

Neurala Raises $14 Million

February 22, 2017

Palo Alto – February 22, 2017 – Cooley advised Neurala – the software company that has invented The Neurala Brain, a deep learning neural networks platform that is making smart products like toys, cameras and self-driving cars more autonomous, interactive and useful – on its $14 million Series A financing.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related contacts

Joshua Rottner
Partner, Boston

Related Practices & Industries

Tarveda Raises $30 Million Series D Financing

February 2, 2017

Cooley advised Tarveda Therapeutics on its $30 million Series D financing round. New investor Versant Ventures led the round, which also included existing investors New Enterprise Associates, Novo A/S, NanoDimension and Flagship Pioneering.

Read more

Related contacts

Marc Recht
Partner, Boston
Joshua Rottner
Partner, Boston
Michael Rohr
Partner, Boston

Related Practices & Industries

Dyn Sells to Oracle

November 21, 2016

Cooley advised Dyn on its sale to Oracle. Dyn, based in Manchester, New Hampshire, is the leading cloud-based Internet Performance and DNS provider.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Pat Mitchell
Partner, Boston
Jacqueline Grise
Partner, Washington DC
Joshua Rottner
Partner, Boston
Giselle Rivers
Partner, Boston
Sharon Connaughton
Special Counsel, Washington DC

Related Practices & Industries

View more